The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Nolvasan SuspensionThis page contains information on Nolvasan Suspension for veterinary use.
The information provided typically includes the following:
- Nolvasan Suspension Indications
- Warnings and cautions for Nolvasan Suspension
- Direction and dosage information for Nolvasan Suspension
Nolvasan SuspensionThis treatment applies to the following species:
NADA 010-434, Approved by FDA
For prevention and treatment of metritis and vaginitis in mares caused by pathogens sensitive to chlorhexidine hydrochloride.
For Use in Horses Only
Each 28 mL syringe contains 1 g chlorhexidine hydrochloride in a special base.
ADMINISTRATION: Unattached placental membranes and any excess uterine fluid or debris should be removed from the uterus. The external genitalia should be carefully cleaned and a clean, sterile inseminating pipette should be passed through the cervix and the Nolvasan Suspension infused into the uterus.
Treatment may be repeated in 48 to 72 hours.
Store at controlled room temperature 15° to 30°C (59° to 86°F).
Keep out of reach of children.
WarningNot for use in horses intended for food.
NDC 0856-1050-01 - 0.95 Fl Oz (28 mL)
Fort Dodge Animal Health, Fort Dodge, Iowa 50501 USA
NAC No.: 10031372
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Customer Service:||800-733-5500 and 800-793-0596|
|Veterinary Medical Investigations & Product Support:||800-366-5288|
|Technical Services (USA):||800-366-5288|
|Every effort has been made to ensure the accuracy of the Nolvasan Suspension information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-04-26